CIK 0001798749
- Emerging growth company
Jade Biosciences, Inc.
Sign in to watch- Ticker
- JBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831377888
- Phone
- +1 781-312-3013
- Business address
- 221 CRESCENT ST., BUILDING 23, SUITE 105, WALTHAM, MA, 02453
- Former names
- Aerovate Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-18 | Dake Benjamin T SEE REMARKS | Option exercise · Stock Option (Right to Buy) 10b5-1 | −14,500 | 43,500 | ||
| 2024-03-13 | Eldridge George A SEE REMARKS | Option exercise 10b5-1 | +2,016 | $2.14 | $4K | 3,976 |
| 2024-03-13 | Eldridge George A SEE REMARKS | Sale 10b5-1 | −2,016 | $25.02 | $50K | 1,960 |
| 2024-03-13 | Eldridge George A SEE REMARKS | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,016 | 51,263 | ||
| 2024-03-12 | Eldridge George A SEE REMARKS | Option exercise 10b5-1 | +2,051 | $2.14 | $4K | 4,011 |
| 2024-03-12 | Eldridge George A SEE REMARKS | Sale 10b5-1 | −2,051 | $25.05 | $51K | 1,960 |
| 2024-03-12 | Eldridge George A SEE REMARKS | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,051 | 53,279 | ||
| 2024-03-11 | Eldridge George A SEE REMARKS | Option exercise 10b5-1 | +3,433 | $2.14 | $7K | 5,393 |
| 2024-03-11 | Eldridge George A SEE REMARKS | Sale 10b5-1 | −3,423 | $25.24 | $86K | 1,970 |
| 2024-03-11 | Eldridge George A SEE REMARKS | Sale 10b5-1 | −10 | $26.31 | $263 | 1,960 |
| 2024-03-11 | Eldridge George A SEE REMARKS | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,433 | 55,330 | ||
| 2024-03-08 | Eldridge George A SEE REMARKS | Option exercise 10b5-1 | +114 | $2.14 | $244 | 2,074 |
| 2024-03-08 | Eldridge George A SEE REMARKS | Sale 10b5-1 | −114 | $25.00 | $3K | 1,960 |
| 2024-03-08 | Eldridge George A SEE REMARKS | Option exercise · Stock Option (Right to Buy) 10b5-1 | −114 | 58,763 | ||
| 2024-03-07 | Eldridge George A SEE REMARKS | Option exercise 10b5-1 | +22,386 | $2.14 | $48K | 24,346 |
| 2024-03-07 | Eldridge George A SEE REMARKS | Sale 10b5-1 | −22,386 | $25.00 | $560K | 1,960 |
| 2024-03-07 | Eldridge George A SEE REMARKS | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,400 | 28,263 | ||
| 2024-03-07 | Eldridge George A SEE REMARKS | Option exercise · Stock Option (Right to Buy) 10b5-1 | −20,986 | 58,877 | ||
| 2024-03-07 | Gillies Hunter CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +8,975 | $2.14 | $19K | 12,226 |
| 2024-03-07 | Gillies Hunter CHIEF MEDICAL OFFICER | Sale 10b5-1 | −8,975 | $24.50 | $220K | 3,251 |
Page 7 of 16 · 315 trades